Top Markets
Coin of the day
PharmaSGP Holding SE PharmaSGP Holding SE

PharmaSGP Holding SE

PSG
Rankning i aktier #14723
Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE... Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.
Aktiekurs
$34.40
Senast synkroniserad: 2025-08-11
Marknadsvärde
$396.01M
Förändring (1 dag)
1.83%
Förändring (1 år)
0.00%
Land
DE
Handel PharmaSGP Holding SE (PSG)

Kategori

P/B-tal för PharmaSGP Holding SE (PSG)
P/B-tal per 2026 TTM: 0
Enligt PharmaSGP Holding SE senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 0. I slutet av 2026 hade företaget ett P/B-tal på 0.
Historik för P/B-tal för PharmaSGP Holding SE från 2026 till 2026
P/B-tal vid årets slut
År P/B-tal Ändra
Inte tillräckligt med data för de angivna datumen.
P/B-tal för liknande företag eller konkurrenter